Your browser doesn't support javascript.
Characterization of the Inflammatory Response to Severe COVID-19 Illness.
McElvaney, Oliver J; McEvoy, Natalie L; McElvaney, Oisín F; Carroll, Tomás P; Murphy, Mark P; Dunlea, Danielle M; Ní Choileáin, Orna; Clarke, Jennifer; O'Connor, Eoin; Hogan, Grace; Ryan, Daniel; Sulaiman, Imran; Gunaratnam, Cedric; Branagan, Peter; O'Brien, Michael E; Morgan, Ross K; Costello, Richard W; Hurley, Killian; Walsh, Seán; de Barra, Eoghan; McNally, Cora; McConkey, Samuel; Boland, Fiona; Galvin, Sinead; Kiernan, Fiona; O'Rourke, James; Dwyer, Rory; Power, Michael; Geoghegan, Pierce; Larkin, Caroline; O'Leary, Ruth Aoibheann; Freeman, James; Gaffney, Alan; Marsh, Brian; Curley, Gerard F; McElvaney, Noel G.
  • McElvaney OJ; Department of Medicine.
  • McEvoy NL; Beaumont Hospital, Dublin, Ireland; and.
  • McElvaney OF; Department of Anaesthesia and Critical Care.
  • Carroll TP; Department of Medicine.
  • Murphy MP; Beaumont Hospital, Dublin, Ireland; and.
  • Dunlea DM; Department of Medicine.
  • Ní Choileáin O; Department of Medicine.
  • Clarke J; Department of Medicine.
  • O'Connor E; Beaumont Hospital, Dublin, Ireland; and.
  • Hogan G; Department of Anaesthesia and Critical Care.
  • Ryan D; Beaumont Hospital, Dublin, Ireland; and.
  • Sulaiman I; Beaumont Hospital, Dublin, Ireland; and.
  • Gunaratnam C; Department of Anaesthesia and Critical Care.
  • Branagan P; Beaumont Hospital, Dublin, Ireland; and.
  • O'Brien ME; Beaumont Hospital, Dublin, Ireland; and.
  • Morgan RK; Department of Medicine.
  • Costello RW; Beaumont Hospital, Dublin, Ireland; and.
  • Hurley K; Beaumont Hospital, Dublin, Ireland; and.
  • Walsh S; Beaumont Hospital, Dublin, Ireland; and.
  • de Barra E; Beaumont Hospital, Dublin, Ireland; and.
  • McNally C; Beaumont Hospital, Dublin, Ireland; and.
  • McConkey S; Beaumont Hospital, Dublin, Ireland; and.
  • Boland F; Beaumont Hospital, Dublin, Ireland; and.
  • Galvin S; Department of International Health and Tropical Medicine, and.
  • Kiernan F; Beaumont Hospital, Dublin, Ireland; and.
  • O'Rourke J; Department of International Health and Tropical Medicine, and.
  • Dwyer R; Data Science Centre, Division of Biostatistics and Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Power M; Beaumont Hospital, Dublin, Ireland; and.
  • Geoghegan P; Beaumont Hospital, Dublin, Ireland; and.
  • Larkin C; Beaumont Hospital, Dublin, Ireland; and.
  • O'Leary RA; Beaumont Hospital, Dublin, Ireland; and.
  • Freeman J; Beaumont Hospital, Dublin, Ireland; and.
  • Gaffney A; Beaumont Hospital, Dublin, Ireland; and.
  • Marsh B; Beaumont Hospital, Dublin, Ireland; and.
  • Curley GF; Beaumont Hospital, Dublin, Ireland; and.
  • McElvaney NG; Beaumont Hospital, Dublin, Ireland; and.
Am J Respir Crit Care Med ; 202(6): 812-821, 2020 09 15.
Article in English | MEDLINE | ID: covidwho-614625
ABSTRACT
Rationale Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory characteristics are incompletely understood.

Objectives:

To define the cytokine profile of COVID-19 and to identify evidence of immunometabolic alterations in those with severe illness.

Methods:

Levels of IL-1ß, IL-6, IL-8, IL-10, and sTNFR1 (soluble tumor necrosis factor receptor 1) were assessed in plasma from healthy volunteers, hospitalized but stable patients with COVID-19 (COVIDstable patients), patients with COVID-19 requiring ICU admission (COVIDICU patients), and patients with severe community-acquired pneumonia requiring ICU support (CAPICU patients). Immunometabolic markers were measured in circulating neutrophils from patients with severe COVID-19. The acute phase response of AAT (alpha-1 antitrypsin) to COVID-19 was also evaluated.Measurements and Main

Results:

IL-1ß, IL-6, IL-8, and sTNFR1 were all increased in patients with COVID-19. COVIDICU patients could be clearly differentiated from COVIDstable patients, and demonstrated higher levels of IL-1ß, IL-6, and sTNFR1 but lower IL-10 than CAPICU patients. COVID-19 neutrophils displayed altered immunometabolism, with increased cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1α (hypoxia-inducible factor-1α), and lactate. The production and sialylation of AAT increased in COVID-19, but this antiinflammatory response was overwhelmed in severe illness, with the IL-6AAT ratio markedly higher in patients requiring ICU admission (P < 0.0001). In critically unwell patients with COVID-19, increases in IL-6AAT predicted prolonged ICU stay and mortality, whereas improvement in IL-6AAT was associated with clinical resolution (P < 0.0001).

Conclusions:

The COVID-19 cytokinemia is distinct from that of other types of pneumonia, leading to organ failure and ICU need. Neutrophils undergo immunometabolic reprogramming in severe COVID-19 illness. Cytokine ratios may predict outcomes in this population.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thyroid Hormones / Carrier Proteins / Alpha 1-Antitrypsin / Cytokines / Acute-Phase Reaction / Coronavirus Infections / Lactic Acid / Hypoxia-Inducible Factor 1, alpha Subunit / Membrane Proteins Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Am J Respir Crit Care Med Journal subject: Critical Care Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thyroid Hormones / Carrier Proteins / Alpha 1-Antitrypsin / Cytokines / Acute-Phase Reaction / Coronavirus Infections / Lactic Acid / Hypoxia-Inducible Factor 1, alpha Subunit / Membrane Proteins Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: Am J Respir Crit Care Med Journal subject: Critical Care Year: 2020 Document Type: Article